Fetal hemoglobin

Mar 17, 2020

Sickle Cell Anemia Industry Outlook to 2026 Featuring CRISPR Therapeutics, Global Blood Therapeutics, Novartis, Pfizer, and Vertex Pharmaceuticals

Jan 22, 2020

Aruvant Receives Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease

Aug 13, 2019

A Platform for Screening Drugs To Treat Sickle Cell Disease Now Offered by ReachBio Research Labs

Jun 18, 2019

Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687

Dec 03, 2018

Aruvant Sciences Presents Data from Ongoing Clinical Study of Lentiviral Gene Therapy RVT-1801 for Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

Dec 01, 2018

Studies Show Improved Sickle Cell Disease Outcomes Worldwide

Dec 01, 2018

Sickle Cell Anemia Treatment Safely Lowers Disease Burden in African Children

Nov 26, 2018

Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children's Hospital Medical Center

Aug 21, 2018

Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in retail pharmacies

Jun 23, 2017

European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing